| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 183,344 | 105,560 | 89,056 | 80,046 | | Cost of Revenue | 139,382 | 81,890 | 73,888 | 62,142 | | | Gross Profit | 43,962 | 23,670 | 15,168 | 17,904 | | | Operating Expenses | | Research Development | 18,853 | 18,432 | 20,570 | 20,812 | | Selling General and Administrative | 16,209 | 14,160 | 14,364 | 13,949 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 8,900 | (8,922) | (19,766) | (16,857) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 223 | 568 | 439 | (2,490) | | Earnings Before Interest And Taxes | 8,675 | (8,354) | (19,327) | (19,347) | | Interest Expense | (204) | 204 |
-
|
-
| | Income Before Tax | 8,879 | (8,558) | (19,327) | (19,347) | | Income Tax Expense | 961 | 1,188 | 844 | (921) | | Minority Interest |
-
|
-
| 119 | 235 | | | | Net Income From Continuing Ops | 7,974 | (9,746) | (20,052) | (18,191) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 7,974 | (9,746) | (20,052) | (18,191) | | Preferred Stock And Other Adjustments | 110 | (110) |
-
|
-
| | | Net Income Applicable To Common Shares | $8,084 | ($9,856) | ($20,052) | ($18,191) |
|
0.51% Nasdaq 
Income Statement
